Science Explorer Interactive view Map
Company · Trenčín · Slovakia

Heidenhain (Slovakia)

Research works
2
▲ 314% vs 2013–17
Citations
19
8.6 per fractional work
Top-10% rate
8.3%
record average 16.5%
Open access
83%
world 28%

Not ranked overall: Heidenhain (Slovakia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Heidenhain (Slovakia) publish most on?

By volume in 2022–2025: Renal cell carcinoma treatment, Ferroptosis and cancer prognosis, Multiple and Secondary Primary Cancers and Privacy-Preserving Technologies in Data.

  1. 1 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  2. 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  3. 3 Multiple and Secondary Primary Cancers Epidemiology 0 works
  4. 4 Privacy-Preserving Technologies in Data Artificial Intelligence 0 works
  5. 5 Cryptography and Data Security Artificial Intelligence 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available83.2%not open16.8%

World: 28% of research is openly available.

with international co-authors54.8%domestic only45.2%

World: 19% is written across borders.

How has Heidenhain (Slovakia)'s research output changed?

Output in 2018–2022 was 314% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Trenčín

All research institutions in Trenčín

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.